SU552084A1 - Lithium hydroxybutyrate agent for the treatment of manic-depressive psychosis and paroxysmal schizophrenia - Google Patents

Lithium hydroxybutyrate agent for the treatment of manic-depressive psychosis and paroxysmal schizophrenia

Info

Publication number
SU552084A1
SU552084A1 SU1740284A SU1740284A SU552084A1 SU 552084 A1 SU552084 A1 SU 552084A1 SU 1740284 A SU1740284 A SU 1740284A SU 1740284 A SU1740284 A SU 1740284A SU 552084 A1 SU552084 A1 SU 552084A1
Authority
SU
USSR - Soviet Union
Prior art keywords
lithium
manic
hydroxybutyrate
schizophrenia
treatment
Prior art date
Application number
SU1740284A
Other languages
Russian (ru)
Inventor
Александр Прокофьевич Арендарук
Александр Петрович Сколдинов
Василий Васильевич Закусов
Борис Иванович Любимов
Владимир Алексеевич Загоревский
Галина Ивановна Завидовская
Андрей Владимирович Снежневский
Анатолий Болиславович Смулевич
Original Assignee
Институт фармакологии АМН СССР
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт фармакологии АМН СССР filed Critical Институт фармакологии АМН СССР
Priority to SU1740284A priority Critical patent/SU552084A1/en
Application granted granted Critical
Publication of SU552084A1 publication Critical patent/SU552084A1/en

Links

Description

Дл  лечени  примен ют суточные дозы от 1,0 до 2,5 г оксибутирата лити .Daily doses of 1.0 to 2.5 g of lithium hydroxybutyrate are used for treatment.

Клинические испытани  оксибутирата лити  на больных показали, что препарат  вл етс  эффективным средством лечени  при маниакально-депрессивном психозе и шизофрении € периодическим и приступопроградиентным течением. Кроме того, препарат примен ют в качестве средства профилактики аффективных приступов.Clinical trials of lithium oxybutyrate in patients have shown that the drug is an effective treatment for manic-depressive psychosis and schizophrenia with a periodic and phytosophageal course. In addition, the drug is used as a means of preventing affective attacks.

Claims (1)

1. БМЭ, М. Энциклопеди , т. 16, 1960, с. 97-98.1. BME, M. Encyclopedia, V. 16, 1960, p. 97-98.
SU1740284A 1972-01-13 1972-01-13 Lithium hydroxybutyrate agent for the treatment of manic-depressive psychosis and paroxysmal schizophrenia SU552084A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU1740284A SU552084A1 (en) 1972-01-13 1972-01-13 Lithium hydroxybutyrate agent for the treatment of manic-depressive psychosis and paroxysmal schizophrenia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU1740284A SU552084A1 (en) 1972-01-13 1972-01-13 Lithium hydroxybutyrate agent for the treatment of manic-depressive psychosis and paroxysmal schizophrenia

Publications (1)

Publication Number Publication Date
SU552084A1 true SU552084A1 (en) 1977-03-30

Family

ID=20500865

Family Applications (1)

Application Number Title Priority Date Filing Date
SU1740284A SU552084A1 (en) 1972-01-13 1972-01-13 Lithium hydroxybutyrate agent for the treatment of manic-depressive psychosis and paroxysmal schizophrenia

Country Status (1)

Country Link
SU (1) SU552084A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0616804A1 (en) * 1993-03-26 1994-09-28 LABORATORIO FARMACEUTICO C.T. S.r.l. Gamma-hydroxybutyric acid salts possessing anxiolytic activity and suitable for the treatment of states of depression
EP0635265A1 (en) * 1993-07-22 1995-01-25 LABORATORIO FARMACEUTICO C.T. S.r.l. Controlled release pharmaceutical compositions based on one or more pharmaceutically acceptable salts of gamma hydroxy-butyric acid
RU2677879C1 (en) * 2017-10-11 2019-01-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет" (ФГБОУ ВО "ВГУ") Lithio-beta-phenyl-gamma-aminobutyrate as mood stabilizing agent

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0616804A1 (en) * 1993-03-26 1994-09-28 LABORATORIO FARMACEUTICO C.T. S.r.l. Gamma-hydroxybutyric acid salts possessing anxiolytic activity and suitable for the treatment of states of depression
EP0635265A1 (en) * 1993-07-22 1995-01-25 LABORATORIO FARMACEUTICO C.T. S.r.l. Controlled release pharmaceutical compositions based on one or more pharmaceutically acceptable salts of gamma hydroxy-butyric acid
RU2677879C1 (en) * 2017-10-11 2019-01-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет" (ФГБОУ ВО "ВГУ") Lithio-beta-phenyl-gamma-aminobutyrate as mood stabilizing agent

Similar Documents

Publication Publication Date Title
AU5678773A (en) Treatment of teeth
NO138566C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2,1,3-BENZOTIADIAZOLE DERIVATIVES
NO145056C (en) (S) -1-ARYLOXY-2-PROPANOLE DERIVATIVES FOR THE PREPARATION OF THERAPEUTIC ACTIVE (S) -1-ARYLOXY-3-AMINO-2-PROPANOLE DERIVATIVES
AR203377A1 (en) PROCEDURE TO PREPARE DERIVATIVES OF CYCLOPENTENOPYRIDINE-, TETRAHIDROQUINOLIN- AND CYCLOHEPTENOPYRIDINE-THIOCARBOXAMIDAS, AND INTERMEDIATE SUBSTANCES OBTAINED DURING THE SAME
DK132573C (en) SKIN TREATMENT PREPARATION
NO137899C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE N (1H-TETRAZOL-5-YL) -KINAL DAMIDES
SU552084A1 (en) Lithium hydroxybutyrate agent for the treatment of manic-depressive psychosis and paroxysmal schizophrenia
GB1368201A (en) Treatment of diseases of the skin and mucosa
BE798119A (en) APPLICATION OF BICYCLIC OXAZOLIDINES AS ANTIMICROBIAL ACTIVE SUBSTANCES
IL41897A (en) Medical light and combating of hyperbilirubinemia
NO141651C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AROYL-SUBSTITUTED PHENYLEDIC ACETIC ACID DERIVATIVES
NO141648C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTIC ACTIVE 2-OXAZOLINE DERIVATIVES
NO139035C (en) PROCEDURE FOR TREATMENT OF UREA GRANULES
FI49677C (en) Dental care agent to prevent the formation of dental plaque.
NO143064C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE HYDROXYLYCYLXANTINES
DOP1971001881A (en) TREATMENT OF TEETH
FI54100B (en) FRAMEWORK FOR THERAPEUTIC TREATMENT OF THERAPEUTIC TRICYCLES
NO139088C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2BETA, 16BETA-DIAMINO-5ALFA-ANDROSTANES
GB1374159A (en) Purification of human blood
NO142077C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE N- (1-CYCLOHEXYL-3-PYRROLIDINYL) -BENZAMIDES
BE867396A (en) NEW MEDICINE USEFUL IN THE TREATMENT OF BACTERIAL DISORDERS
SE392722B (en) PROCEDURE FOR THE PREPARATION OF OXAZOLIDINE DERIVATIVES WITH THERAPEUTIC EFFECT
NO144344C (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE N-ARYLSULPHONYL N`- (3-AZABICYCLOALKYL)
BE820222A (en) THERAPEUTIC COMPOSITION FOR THE TREATMENT OF ORAL DIABETES
SE403612B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF ANTIBACTERIAL ACTIVE HEXAMETHYLENE-BIS-BIGUANIDS